Allan-Herndon-Dudley syndrome in Hong Kong: Implication for newborn screening

Abstract

<h3>Background</h3><p>Allan-Herndon-Dudley syndrome (MCT 8 deficiency) is an X-linked recessive condition caused by hemizygous pathogenic variants in <em>SLC16A2</em> encoding the monocarboxylate transporter 8 (MCT8). Patients present with global developmental delay and neurological impairment, and abnormal serum thyroid function tests. The drug, 3,3′,5 triiodothyroacetic acid (TRIAC), was recently demonstrated to improve the endocrinological profile. Improvement in diagnostic approach is key to earlier start of treatment.</p><h3>Patient findings</h3><p>We described four Chinese patients with <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/monocarboxylate-transporter-8" title="Learn more about MCT8 from ScienceDirect's AI-generated Topic Pages">MCT8</a> deficiency undergoing different diagnostic odysseys. Their initial presentation included global developmental delay and dystonia. Patient 2 also had epilepsy. Patients 1 and 2 presented with two novel variants: (1)hemizygous NM_006517.4(<em>SLC16A2</em>):c.1170 + 2 T > A; p.(?), and (2)hemizygous NM_006517.4(<em>SLC16A2</em>):c.305dupT; p.(Val103GlyfsTer17) respectively. Patients 3 and 4 were biological brothers harboring hemizygous NM_006517.4(<em>SLC16A2</em>):c.305dupT; p.(Val103GlyfsTer17), which was first reported in 2004. We obtained the measurement of triiodothyronine (T3) and reverse T3 (rT3) from dried blood spot samples collected on Day 1 of life from Patient 1 and studied the biomarkers (rT3 and T3/rT3 ratio) proposed by Iwayama et al. for the detection of MCT8 deficiency at birth. Our data verified the significantly reduced rT3 level in Patient 1, compared with healthy newborns, although low T3 level and comparable T3/rT3 ratio with controls were detected.</p><h3>Summary</h3><p>Patients with MCT8 deficiency often undergo diagnostic odysseys. An early diagnosis could be missed by a normal <a href="https://www.sciencedirect.com/topics/medicine-and-dentistry/neonatal-infant" title="Learn more about newborn from ScienceDirect's AI-generated Topic Pages">newborn</a> thyroid function screening result based on biochemical measurement of TSH and/or T4/fT4. Early detection of rT3 is key to improving current diagnostic approach.</p><h3>Conclusion</h3><p>We recommend that full thyroid function profile (TSH, T4/fT4, T3/fT3, rT3) be considered early for all pediatric patients presenting with unexplained developmental delay and/or dystonia. The potential inclusion of rT3 measurement in newborn screening may prove promising.</p>